Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8(+) T-cell response.
about
Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirusImmune regulation of human herpesviruses and its implications for human transplantationClinical immune-monitoring strategies for predicting infection risk in solid organ transplantationMolecular Imprint of Exposure to Naturally Occurring Genetic Variants of Human Cytomegalovirus on the T cell RepertoireEBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted functionEffects of donor/recipient human leukocyte antigen mismatch on human cytomegalovirus replication following liver transplantationLower proportion of naïve peripheral CD8+ T cells and an unopposed pro-inflammatory response to human Cytomegalovirus proteins in vitro are associated with longer survival in very elderly people.Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiferon gamma interferon-releasing assays in assessing risk of CMV infection in kidney transplant recipients.Immunobiology of human cytomegalovirus: from bench to bedside.Age-dependent association between low frequency of CD27/CD28 expression on pp65 CD8+ T cells and cytomegalovirus replication after transplantation.CD4+ T cell help has an epitope-dependent impact on CD8+ T cell memory inflation during murine cytomegalovirus infection.T cell mediated suppression of neurotropic coronavirus replication in neural precursor cells.Cytomegalovirus in pregnancy and the neonate.Understanding human T-cell-mediated immunoregulation through herpesviruses.Immunological risk factors for infection after immunosuppressive and biologic therapies.Human herpesvirus vaccines and future directions.Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation.Narrowing of T-cell receptor beta variable repertoire during symptomatic herpesvirus infection in transplant patients.Pretransplant immediately early-1-specific T cell responses provide protection for CMV infection after kidney transplantation.Pretransplant interferon-γ secretion by CMV-specific CD8+ T cells informs the risk of CMV replication after transplantation.Clinical validation of a novel ELISpot-based in vitro diagnostic assay to monitor CMV-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study.Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme.QuantiFERON®-CMV assay for the assessment of cytomegalovirus cell-mediated immunity
P2860
Q21092179-81FC9725-AE6A-45AC-8007-7DD1EA671EF1Q26992146-BB5D4BFA-84ED-43ED-8FC7-16C386228E0AQ26998832-DD6C82D5-2320-4F91-8E5A-DC0A9CBC6DC1Q27681653-CC81353A-9F88-45ED-ABD3-1243423F3B59Q34186560-573A4169-48FB-4ACD-8AC3-7B1A868B32B3Q35134243-29308E96-876B-428A-8D5F-B4E44B6633D2Q36993437-BC9C375A-0848-4A8D-B632-6826173E0B77Q37036219-4705EEC5-532F-4679-98E1-84223BB6A5BAQ37050965-05A831EF-DE50-43B2-98AB-AE99B63C17ADQ37374672-CD3A2541-2077-4995-8842-BEF61A10DBABQ37397130-CC9718C6-41CB-4063-A42D-AA0C02C2C8C2Q37489374-CD1A5959-A94E-486B-9C13-5EF5C14AB3CBQ37643347-48F3D840-ADAA-4714-8A10-D763649B4FC0Q37837487-F20643FD-F261-4CBA-8C8D-519534EB3B8FQ37866813-551E980B-6C2C-4A7D-A007-CC3135FC44DFQ39476453-EAAD3B57-4E07-4DF6-9610-B36EF45B6F95Q40115981-2A102840-41F8-4B66-B3EF-E074E3827FBDQ43489588-4349A053-6392-48B2-91E3-2829D386A4A0Q43653857-B5F738B0-0FC0-4378-8593-0A2E75C603B0Q45391655-C311CFC3-CA95-46EC-804A-8A68896875E1Q47249337-9E37EE2C-E320-4269-A4B5-7B4B11035EBDQ55462188-ECE225E7-9E94-4A8A-ABBC-C6F75AE296B7Q58074723-703A7106-2054-4F7C-B692-FD93DCD35BC5
P2860
Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8(+) T-cell response.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Symptomatic and asymptomatic v ...... ecific CD8(+) T-cell response.
@ast
Symptomatic and asymptomatic v ...... ecific CD8(+) T-cell response.
@en
type
label
Symptomatic and asymptomatic v ...... ecific CD8(+) T-cell response.
@ast
Symptomatic and asymptomatic v ...... ecific CD8(+) T-cell response.
@en
prefLabel
Symptomatic and asymptomatic v ...... ecific CD8(+) T-cell response.
@ast
Symptomatic and asymptomatic v ...... ecific CD8(+) T-cell response.
@en
P2093
P2860
P356
P1433
P1476
Symptomatic and asymptomatic v ...... ecific CD8(+) T-cell response.
@en
P2093
Andrew Galbraith
Chrysa Fazou
Julissa Weiss
Keith McNeil
Miles P Davenport
Rajiv Khanna
Scott C Bell
Scott Campbell
Tania Crough
P2860
P304
11538-11542
P356
10.1128/JVI.00581-07
P407
P577
2007-08-08T00:00:00Z